Michele Oneil/Legacy Builders
What you need to know about this purported money-making opportunity.
Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)
Similasan Eye Relief products
Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”
Settled
(Final approval granted)
https://www.homeopathiceyedropsettlement.com/home
What you need to know about this purported money-making opportunity.
How a donation made on this fundraising platform can turn into a costly transaction.
Lawsuits accuse tax prep companies of violating the Military Lending Act.
Katie Mather, HuffPost
TINA.org digs into company’s subscription terms.